Clinical Pharmacist-Led Medication Reconciliation Initiative at a Newly Established Hospital in Qatar: A Preliminary Report

Sonallah, Hala; Ibrahim, Tarek; Sattar, Dalia Abdul; Ahmed, Dalia; Ibrahim, Mohamed Izham Mohamed

doi:10.23937/2469-5823/1510083

Cited by 1 publication

(1 citation statement)

References 7 publications

(13 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…15 In line with the gold standards of Joint Commission International, clinical pharmacists have joint forces to minimize ADEs and improve patient safety by preventing medication errors across diverse clinical practice settings in Qatar. [16][17][18] In Qatar, however, there are no published summative reports that describe the clinical pharmacy interventions in practices, including cancer care. In the current study, therefore, we sought to analyze the nature and types of the clinical pharmacy interventions taking place as part of care for hospitalized cancer patients in the primary tertiary cancer care provider in Qatar, the National Center for Cancer Care and Research (NCCCR).…”

Section: Introductionmentioning

confidence: 99%

Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar

Dali

Al‐Badriyeh

Gulied

et al. 2023

J Oncol Pharm Pract

View full text Add to dashboard Cite

Introduction Drug-related problems (DRPs) affect the health outcomes of patients during hospitalization. We sought to analyze the clinical pharmacist-documented interventions among hospitalized patients in the cancer hospital in Qatar. Methods A retrospective analysis of electronically reported clinical pharmacist interventions of patients admitted to cancer units at Hamad Medical Corporation, Qatar was conducted. Extracted data was based on an overall 3-month follow-up period; March 1–31, 2018, July 15–August 15, 2018 and January 1–31, 2019. Categorical variables were expressed as frequencies and percentages, while continuous variables were expressed as mean ± standard deviation (SD). Results A total of 281 cancer patients with 1354 interventions were included. The average age of the study participants was 47 years (SD ± 17.36). The majority of the study population was females ( n = 154, 54.80%). The prevailing pharmacist intervention was the addition of a drug therapy ( n = 305, 22.53%), followed by medication discontinuation ( n = 288, 21.27%) and the addition of a prophylactic agent ( n = 174, 12.85%). This pattern was similar across all subgroups (i.e., gender, age, ward), except for the urgent care unit, where an increase in medication dose was the third highest frequently identified intervention ( n = 3, 0.22%). The two medication groups associated with the majority of interventions were the anti-infective and fluid/electrolyte agents. Most of the interventions documented were in the oncology ward (73.19%), while the urgent care unit had the least documented interventions (1.62%). Conclusions Our analysis showed that clinical pharmacists can effectively identify and prevent DRPs among hospitalized cancer patients.

show abstract